Bio-Path Holdings, Inc.
BPTH
$0.06
-$0.01-15.67%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -58.56% | -59.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -89.30% | 40.76% | |||
| Operating Income | 89.30% | -40.76% | |||
| Income Before Tax | 78.77% | -61.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 78.77% | -61.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 78.77% | -61.19% | |||
| EBIT | 89.30% | -40.76% | |||
| EBITDA | 89.47% | -40.48% | |||
| EPS Basic | 79.31% | -36.99% | |||
| Normalized Basic EPS | 79.29% | -37.00% | |||
| EPS Diluted | 79.31% | -36.99% | |||
| Normalized Diluted EPS | 79.29% | -37.00% | |||
| Average Basic Shares Outstanding | 2.56% | 17.64% | |||
| Average Diluted Shares Outstanding | 2.56% | 17.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||